Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al.

Roy O. Mathew; Elvira O. Gosmanova; Mandeep S. Sidhu

doi:10.1007/s10557-018-6803-0

Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al.

Roy O. Mathew, Elvira O. Gosmanova, Mandeep S. Sidhu

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	241-243
Number of pages	3
Journal	Cardiovascular Drugs and Therapy
Volume	32
Issue number	3
DOIs	https://doi.org/10.1007/s10557-018-6803-0
State	Published - Jun 1 2018
Externally published	Yes

ASJC Scopus Subject Areas

Pharmacology
Cardiology and Cardiovascular Medicine
Pharmacology (medical)

Access to Document

10.1007/s10557-018-6803-0

OpenUrl availability

Full text

Cite this

Mathew, R. O., Gosmanova, E. O., & Sidhu, M. S. (2018). Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al. Cardiovascular Drugs and Therapy, 32(3), 241-243. https://doi.org/10.1007/s10557-018-6803-0

Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al. / Mathew, Roy O.; Gosmanova, Elvira O.; Sidhu, Mandeep S.
In: Cardiovascular Drugs and Therapy, Vol. 32, No. 3, 01.06.2018, p. 241-243.

Research output: Contribution to journal › Editorial › peer-review

Mathew, RO, Gosmanova, EO & Sidhu, MS 2018, 'Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al.', Cardiovascular Drugs and Therapy, vol. 32, no. 3, pp. 241-243. https://doi.org/10.1007/s10557-018-6803-0

Mathew RO, Gosmanova EO, Sidhu MS. Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al. Cardiovascular Drugs and Therapy. 2018 Jun 1;32(3):241-243. doi: 10.1007/s10557-018-6803-0

Mathew, Roy O. ; Gosmanova, Elvira O. ; Sidhu, Mandeep S. / Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease : Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al. In: Cardiovascular Drugs and Therapy. 2018 ; Vol. 32, No. 3. pp. 241-243.

@article{2fd01b08075a44ce99574affd65d060b,

title = "Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al.",

author = "Mathew, {Roy O.} and Gosmanova, {Elvira O.} and Sidhu, {Mandeep S.}",

year = "2018",

month = jun,

day = "1",

doi = "10.1007/s10557-018-6803-0",

language = "English",

volume = "32",

pages = "241--243",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

number = "3",

}

TY - JOUR

T1 - Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease

T2 - Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al.

AU - Mathew, Roy O.

AU - Gosmanova, Elvira O.

AU - Sidhu, Mandeep S.

PY - 2018/6/1

Y1 - 2018/6/1

UR - http://www.scopus.com/inward/record.url?scp=85048765459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048765459&partnerID=8YFLogxK

U2 - 10.1007/s10557-018-6803-0

DO - 10.1007/s10557-018-6803-0

M3 - Editorial

C2 - 29923131

AN - SCOPUS:85048765459

SN - 0920-3206

VL - 32

SP - 241

EP - 243

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

IS - 3

ER -

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this